Treatment pathways for patients with atrial fibrillation

International Journal of Clinical Practice

Volumn 66, Issue 1, 2012, Pages 44-52

  Hodgkinson, J A ^a   Taylor, C J ^a   Hobbs, F D R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CRITICAL PATHWAYS; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; STROKE; WARFARIN; YOUNG ADULT;

EID: 83755174649     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02818.x     Document Type: Article

References (35)

1. Miyasaka Y, Barnes ME, Bailey KR, et al., Mortality trends in patients diagnosed with first atrial fibrillation-a 21-year community study. J Am Coll Cardiol 2007; 49: 986-92.
2. Wolf PA, Abbott RD, Kannell WB,. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22 (8): 983-8.
3. Majeed A, Moser K, Carroll K,. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001; 86: 284-8. (Pubitemid 32800076)
4. Fitzmaurice DA, Hobbs FDR, Jowett S, et al., Screening versus routine practice for detection of atrial fibrillation in people aged 65 or over: cluster randomised controlled trial. BMJ 2007; 335: 383-6. (Pubitemid 47359316)
5. Sopher SM, Camm AJ,. Atrial fibrillation: maintenance of sinus rhythm versus rate control. Am J Cardiol 1996; 77: 24A-37A. (Pubitemid 26061152)
6. Aguilar MI, Hart R,. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke of transient ischaemic attacks. Cochrane Database Syst Rev 2005; 2: CD001927.
7. Lip GYH, Edwards SJ,. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006; 118: 321-33. (Pubitemid 44067199)
8. The ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 2006; 367: 1903-12.
9. Mant J, Hobbs FDR, Fletcher K, et al., Warfarin versus aspirin for stroke prevention in an elderly population with atrial fibrillation (the Birmingham Atrial Fibrillation treatment of the Aged Study, BAFTA): a randomized controlled trial. Lancet 2007; 370: 493-503. (Pubitemid 47212371)
10. National Collaborating Centre for Chronic Conditions. Atrial fibrillation. National clinical guideline for management in primary and secondary care. London, UK: Royal College of Physicians, 2006.
11. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ,. Validation of clinical classification schemes for predicting stroke: results of the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-70. (Pubitemid 32537350)
12. Gage BF, van Walraven C, Pearce L, et al., Selecting patients with atrial fibrillation for anticoagulation. Stroke risk stratification in patients taking aspirin. Circulation 2004; 110: 2287-92. (Pubitemid 39407328)
13. Simpson CR, Wilson C, Hannaford PC, Williams D,. Evidence for age and sex differences in the secondary prevention of stroke in Scottish Primary Care. Stroke 2005; 36: 1771-5. (Pubitemid 41098777)
14. Burton C, Isles C, Norrie J, Hanson R, Grubb E,. The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Br J Gen Pract 2006; 56: 697-702. (Pubitemid 44390244)
15. Mehta PA, Grocott-Mason R, Dubrey SW,. Adherence to anticoagulation guidelines for atrial fibrillation: a district general hospital survey. Br J Cardiol 2004; 11: 474-7. (Pubitemid 39662667)
16. National Institute for Health and Clinical Excellence. Atrial fibrillation. The management of atrial fibrillation costing report. London, UK: NICE, 2006.
17. Fang MC, Stafford RS, Ruskin JN, Singer DE,. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 2004; 164: 55-6.
18. Piccini JP, Hernandez AF, Zhao X, et al., Quality of care for atrial fibrillation among patients hospitalized for heart failure. J Am Coll Cardiol 2009:29; 54 (14): 1280-9.
19. Laguna P, Martin A, del Arco C, Gargantilla P, Investigators in the Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR). Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study. Ann Emerg Med 2004; 44: 3-11. (Pubitemid 38864784)
20. 2 risk score to guide antithrombotic treatment in patients with atrial fibrillation-room for improvement. Swiss Med Wkly 2010; 6: 73-7.
21. Goto S, Bhatt DL, Rother J, et al., Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008; 156: 855-63.
22. Ninios I, Bogossian H, Zarse M, et al., Prevalence, clinical correlates and treatment of permanent atrial fibrillation among the elderly: insights from the first prospective population-based study in rural Greece. J Thromb Thrombolysis 2010; 30: 90-6.
23. Garcia Rodriguez LA, Perez Gutthann S,. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419-26.
24. Andersen PK, Borgan O, Gill RD, Keiding M,. Statistical Models Based on Counting Processes. New York: Springer-Verlag, 1993.
25. Klein JP, Qian C,. Modelling Multistate Survival Illustrated in Bone Marrow Transplantation. Technical Report 15. Milwaukee, WI, USA: Division of Biostatistics, Medical College of Wisconsin, 1996. (accessed February 16 2011).
26. Tsiatis AA,. A large sample study of Cox's regression model. Ann Stat 1981; 9: 93-108.
27. Cutler CS, Lee SJ, Greenberg P, et al., A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004; 104: 579-85. (Pubitemid 38900045)
28. Ruigomez A, Johansson S, Wallander MA, Rodriguez LA,. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002; 55: 358-63. (Pubitemid 34245363)
29. Curtis AB, Seals AA, Safford RE, et al., Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study. Am Heart J 2005; 149: 304-8. (Pubitemid 40348540)
30. Nieuwlaat R, Capucci A, Lip GYH, et al., Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006; 27: 3018-26. (Pubitemid 44963431)
31. Rovenelli A, Folli C, Cardani F, Monzani V,. Thromboembolic and haemorrhagic events in permanent atrial fibrillation: observational study in an emergency department. Eur J Intern Med 2009; 20: 756-9.
32. Mazzaglia G, Filippi A, Alacqua M, et al., A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. Thromb Haemost 2010; 103: 968-75.
33. Osseby GV, Benatru I, Sochurkova D, et al., Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice. Prev Med 2004; 38: 121-8. (Pubitemid 38050283)
34. Reynolds MR, Shah J, Essebag V, et al., Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol 2006; 97: 538-43. (Pubitemid 43190046)
35. Hollowell J,. The general practice research database: quality of morbidity data. Pop Trends 1997; 87: 36-40.